Breaking News
Get 55% Off 0
🗓️ Plan for Wealth: Don't miss this week's most important financial events
See Economic Calendar

IPO Calendar

Sign In / Free Sign Up now to save your preferred filters.
Filters
2026-08-03 - 2027-12-31
 

Country:

Select All
Clear
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
IPO Listing Company Exchange IPO Value IPO Price Last
IPO Listing Company Exchange IPO Value IPO Price Last
Aug 05, 2026 Attovia Therapeutics Inc (ATTO) NASDAQ 212.5M 17.00 22.71
Aug 06, 2026 River City Bank Corp (RCBC) NASDAQ 140.3M 45.00 47.84
Aug 06, 2026 Braveheart Bio Inc (BRVE) NASDAQ 318.8M 18.00 27.66
Aug 06, 2026 Blossomhill Therapeutics Inc (BLSM) NASDAQ 132.8M 16.00 16.38
Aug 06, 2026 Latigo Biotherapeutics Inc (LTGO) NASDAQ 288.0M 18.00 19.30
Aug 12, 2026 Vogenx Inc (VOGX) NASDAQ 81.3M 13.00 15.75
Aug 13, 2026 Robinhood Ventures Fund II (RVII) NYSE 200.0M 25.00 23.60
Aug 14, 2026 Thunder Bridge Capital Partners V (TBCVU) NASDAQ 261.0M 10.00 9.90
Aug 20, 2026 Lyntris Inc (LYNX) NYSE 528.0M 19.00-22.00 -
Aug 20, 2026 Advasa Holdings Inc (ADBT) NASDAQ - -
Oct 23, 2026 Anthropic (ANTP) NASDAQ - -
Nov 27, 2026 OpenAI (OAI) NASDAQ - -

News

Vogenx raises $81.3 million in Nasdaq IPO
Vogenx raises $81.3 million in Nasdaq IPO By Investing.com - 5 hours ago

LOS ANGELES and NEW YORK - Vogenx Inc. (NASDAQ:VOGX), a clinical-stage biopharmaceutical company, completed an initial public offering of $81.3 million, according to a press...

Analysis

Charles-Henry Monchau
Will Smart Glasses Be the Next Smartphone? By Charles-Henry Monchau - Aug 08, 2026

Smart glasses are being presented as the next smartphone. Yet their success may depend less on their technological capabilities than on the trust they manage to inspire.IntroductionSmart glasses are...

Michael Lebowitz
Leverage Turned a Winning Thesis Into a Stupid Bet By Michael Lebowitz - Aug 03, 2026

Leopold Aschenbrenner’s Situational Awareness Fund turned $225 million into as much as $45 billion. Not bad for a 24-year-old with little experience. In June alone, his fund was up 439%...

Lance Roberts
AI Bear Case: What Skeptics Get Right and Wrong By Lance Roberts - Aug 01, 2026

The AI “bear case” isn’t one argument; it’s three. Burry on earnings. Bernstein on circular financing. MIT on revenue. Two are half right. One falls apart on the data. Michael...

Continue with Apple
Continue with Google
or
Sign up with Email